Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CA125”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableWithdrawnNCT04826029
What this trial is testing

Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer

Who this might be right for
Advanced Stage Serous Epithelial Cancer of the OvaryAdvanced Stage Cancer of TubesAdvanced Stage Cancer of Peritoneum
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Ended earlyNCT00926107
What this trial is testing

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Who this might be right for
Ovarian Cancer
Hellenic Cooperative Oncology Group 9
Not applicableStudy completedNCT00987649
What this trial is testing

Ovarian Cancer Risk Estimation in Patients With Pelvic Mass

Who this might be right for
Adnexal MassOvarian Cancer
Fujirebio Diagnostics, Inc. 512
Not applicableStudy completedNCT02326064
What this trial is testing

Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4

Who this might be right for
Ovarian TumorOvarian Cancer
Centre Hospitalier Departemental Vendee 221
Not applicableStudy completedNCT03320213
What this trial is testing

Value of CA125 and Yolk Sac Morphology in Prediction of Pregnancy Outcome in Threatened Miscarriage

Who this might be right for
Threatened Miscarriage in First Trimester
Ain Shams University 192
Not applicableLooking for participantsNCT06232122
What this trial is testing

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chang Gung Memorial Hospital 45
Not applicableUnknownNCT02296307
What this trial is testing

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

Who this might be right for
Ovarian Neoplasms
McGill University 13,600
Not applicableWithdrawnNCT00080639
What this trial is testing

CA-125 in Screening Patients at High Risk for Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Alabama at Birmingham
Not applicableUnknownNCT03982914
What this trial is testing

The Use of HE4 With Simple Ultrasound Rules to Predict Malignancy in a Pelvic Mass

Who this might be right for
Pelvic Mass
The University of Hong Kong 814
Testing effectiveness (Phase 2)Study completedNCT01959672
What this trial is testing

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic CarcinomaStage I Pancreatic Cancer+6 more
University of Nebraska 11
Not applicableStudy completedNCT06977334
What this trial is testing

IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy Detection

Who this might be right for
Ovarian NeoplasmsOvarian CancerOvarian Carcinoma
Maharajgunj Medical Campus 64
Large-scale testing (Phase 3)Study completedNCT00002895
What this trial is testing

Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Medical Research Council 1,400
Not applicableStudy completedNCT02420769
What this trial is testing

Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion

Who this might be right for
Threatened Abortion
Nesreen Abdel Fattah Abdullah Shehata 100
Early research (Phase 1)Looking for participantsNCT04811703
What this trial is testing

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer

Who this might be right for
Metastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more
Hospices Civils de Lyon 15
Not applicableStudy completedNCT00043472
What this trial is testing

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 40
Not applicableUnknownNCT06182917
What this trial is testing

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
West China Second University Hospital 35
Early research (Phase 1)Ended earlyNCT02948426
What this trial is testing

Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
National Cancer Institute (NCI) 18
Not applicableUnknownNCT05801263
What this trial is testing

CtDNA Methylation for Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerCirculating Tumor DNADNA Methylation+5 more
Lei Li 5,000
Not applicableStudy completedNCT01323361
What this trial is testing

CA125 Levels and Other Inflammatory Markers in Laparoscopic Ventral Hernia Repair

Who this might be right for
Hernia
Oslo University Hospital 10
Early research (Phase 1)Looking for participantsNCT06469281
What this trial is testing

Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Regeneron Pharmaceuticals 90
Next Page